Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

AVIRAVIR
23 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in ATEA PHARMACEUTICALS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 610,607 shares of AVIR (ATEA PHARMACEUTICALS INC), worth $2.8M as of 2026-Q2. The position was increased (+2.3% shares). AVIR represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$2.8M

Current Shares

610,607

Total Value Change

-$772,677

Total Shares Change

+524,173

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
610,607
+2.3%
$2.8M0.0%$4.65
27
2026-Q1
Decreased
596,709
-1.8%
$3.2M0.0%$4.82
0
2025-Q4
Decreased
607,792
-2.8%
$2.2M0.0%$3.55
0
2025-Q3
Decreased
624,984
-1.6%
$1.8M0.0%$2.92
0
2025-Q2
Increased
635,282
+4.5%
$2.3M0.0%$3.45
27
2025-Q1
Decreased
607,882
-7.8%
$1.8M0.0%$2.93
0
2024-Q4
Increased
659,527
+1.4%
$2.2M0.0%$3.33
26
2024-Q3
Increased
650,157
+8.5%
$2.2M0.0%$3.44
28
2024-Q2
Decreased
599,363
-2.1%
$2M0.0%$3.31
0
2024-Q1
Increased
612,319
+4.8%
$2.5M0.0%$4.04
27
2023-Q4
Increased
584,326
+0.4%
$1.8M0.0%$3.05
26
2023-Q3
Increased
582,233
+1.4%
$1.7M0.0%$3.00
26
2023-Q2
Increased
573,959
+9.1%
$2.1M0.0%$3.75
28
2023-Q1
Decreased
526,349
-6.8%
$1.8M0.0%$3.27
0
2022-Q4
Increased
564,494
+2.0%
$2.7M0.0%$4.81
27
2022-Q3
Increased
553,324
+29.4%
$3.1M0.0%$5.60
33
2022-Q2
Increased
427,721
+3.2%
$3M0.0%$7.31
27
2022-Q1
Increased
414,597
+4.9%
$3M0.0%$7.08
28
2021-Q4
Increased
395,247
+0.5%
$3.5M0.0%$9.05
27
2021-Q3
Increased
393,179
+100.3%
$13.8M0.0%$32.13
45
2021-Q2
Increased
196,339
+121.0%
$4.2M0.0%$24.41
43
2021-Q1
Increased
88,840
+2.8%
$5.5M0.0%$56.23
28
2020-Q4
New
86,434
-
$3.6M0.0%$41.71
37

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used